Scientists seek perfect dose for DMD heart drug
Knowledge-focused
Not yet recruiting
This study aims to understand how a heart medication called empagliflozin is processed by the bodies of children with Duchenne muscular dystrophy (DMD). Researchers will give the drug to 10 young DMD patients of different ages and sizes and measure its levels in their blood over …
Phase: PHASE1 • Sponsor: Larry W. Markham • Aim: Knowledge-focused
Last updated Apr 02, 2026 06:57 UTC